Novo Nordisk A/S vs Wheaton Precious Metals Corp — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Wheaton Precious Metals Corp trades at $103.33 (market cap $46.54B). The key difference: Novo Nordisk A/S is far larger — about 4.7× Wheaton Precious Metals Corp's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | WPM | |
|---|---|---|
Market Cap | $220.53B | $46.54B |
Sector | Health | Basic Materials |
52-Week High | $71.70 | $165.72 |
52-Week Low | $35.29 | $91.00 |
Enterprise Value | $239.49B | $44.39B |
Dividend Yield | 3.63% | 0.75% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →